153 related articles for article (PubMed ID: 16144898)
1. Taking family history seriously.
Burke W
Ann Intern Med; 2005 Sep; 143(5):388-9. PubMed ID: 16144898
[No Abstract] [Full Text] [Related]
2. Summaries for patients. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: U.S. Preventive Services Task Force recommendations.
Ann Intern Med; 2005 Sep; 143(5):I47. PubMed ID: 16144889
[No Abstract] [Full Text] [Related]
3. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement.
U.S. Preventive Services Task Force
Ann Intern Med; 2005 Sep; 143(5):355-61. PubMed ID: 16144894
[TBL] [Abstract][Full Text] [Related]
4. Preconception counseling for the couple at risk preventing the hereditary breast and ovarian cancer syndrome.
Beller U
Int J Gynecol Cancer; 2010 Oct; 20(11 Suppl 2):S29-30. PubMed ID: 20975358
[No Abstract] [Full Text] [Related]
5. Using genetic analysis to individualize preventive measures for breast and ovarian cancers.
Olopade OI
Nat Clin Pract Oncol; 2006 Apr; 3(4):182-3. PubMed ID: 16596140
[No Abstract] [Full Text] [Related]
6. Genetics: predisposition and management.
Legare RD
Clin Obstet Gynecol; 2011 Mar; 54(1):180-90. PubMed ID: 21278518
[No Abstract] [Full Text] [Related]
7. Summaries for patients. Assessing the genetic risk for BRCA-related breast or ovarian cancer in women: recommendations from the U.S. Preventive Services Task Force.
Ann Intern Med; 2014 Feb; 160(4):I-16. PubMed ID: 25006622
[No Abstract] [Full Text] [Related]
8. Hereditary Breast and ovarian cancer: providing personalized medicine.
Tranin AS
AWHONN Lifelines; 2005; 9(5):372-6. PubMed ID: 16359075
[No Abstract] [Full Text] [Related]
9. Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening.
Paluch-Shimon S; Cardoso F; Sessa C; Balmana J; Cardoso MJ; Gilbert F; Senkus E;
Ann Oncol; 2016 Sep; 27(suppl 5):v103-v110. PubMed ID: 27664246
[No Abstract] [Full Text] [Related]
10. Hereditary breast and ovarian cancer syndrome.
ACOG Committee on Practice Bulletins
Gynecol Oncol; 2009 Apr; 113(1):6-11. PubMed ID: 19309638
[No Abstract] [Full Text] [Related]
11. Summaries for patients. Assessing the genetic risk for BRCA-related breast or ovarian cancer in women: recommendations from the U.S. Preventive Services Task Force.
Ann Intern Med; 2014 Feb; 160(4):I-16. PubMed ID: 24366402
[No Abstract] [Full Text] [Related]
12. Improving surveillance and quality of life of BRCA mutation carriers.
Loman N; Borg A
J Clin Oncol; 2010 Aug; 28(22):e376-7. PubMed ID: 20458044
[No Abstract] [Full Text] [Related]
13. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force.
Nelson HD; Huffman LH; Fu R; Harris EL;
Ann Intern Med; 2005 Sep; 143(5):362-79. PubMed ID: 16144895
[TBL] [Abstract][Full Text] [Related]
14. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement.
Moyer VA;
Ann Intern Med; 2014 Feb; 160(4):271-81. PubMed ID: 24366376
[TBL] [Abstract][Full Text] [Related]
15. Lessons learned from genetic testing.
Esserman L; Kaklamani V
JAMA; 2010 Sep; 304(9):1011-2. PubMed ID: 20810382
[No Abstract] [Full Text] [Related]
16. Prophylactic surgery recommended for BRCA1 carriers.
Cancer Discov; 2014 May; 4(5):OF1. PubMed ID: 24795013
[No Abstract] [Full Text] [Related]
17. Scaring up patients.
Ortolon K
Tex Med; 2008 Aug; 104(8):43-6. PubMed ID: 19306543
[No Abstract] [Full Text] [Related]
18. Preventing familial breast and ovarian cancer: major research advances with little implication.
Ziogas DE; Katsios CS; Roukos DH
Womens Health (Lond); 2011 Mar; 7(2):135-8. PubMed ID: 21410338
[No Abstract] [Full Text] [Related]
19. The need for public education: "Surveillance and risk reduction strategies" for women at risk for carrying BRCA gene mutations.
Nisker JA
J Obstet Gynaecol Can; 2007 Jun; 29(6):510-1. PubMed ID: 17568484
[No Abstract] [Full Text] [Related]
20. Educational-support groups for BRCA mutation carriers satisfy need for information but do not affect emotional distress.
Landsbergen KM; Brunner HG; Manders P; Hoogerbrugge N; Prins JB
Genet Couns; 2010; 21(4):423-37. PubMed ID: 21290972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
